Mallinckrodt to sell Canadian drug manufacturing unit for $250M
September 10, 2019 at 13:41 PM EDT
Mallinckrodt PLC said Tuesday it would sell Canadian drug manufacturer BioVectra Inc. for $250 million, freeing up more cash as it deals with potential liabilities from more than 2,100 lawsuits tied to the opioid crisis.
